Cash Flow Arrowhead Pharmaceuticals, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-612.00
-206.00
-172.00
-140.00
-84.00
68.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
25.00
-51.00
-98.00
226.00
-60.00
87.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-462.00
-153.00
-136.00
171.00
-95.00
173.00
Cash Flow from Investing Activities
-420.00
-96.00
-5.00
-141.00
-240.00
-47.00
Cash Flow from Financing Activities
870.00
253.00
65.00
11.00
257.00
66.00
Net Cash Inflow / Outflow
-8.00
3.00
-76.00
40.00
-78.00
191.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
4.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Arrowhead Pharmaceuticals, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
-612.46
-740.359000001189
128.00
17.28%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
25.091
-10.1040000000162
35.00
348.33%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-462.851
-570.570000000916
108.00
18.88%
Cash Flow from Investing Activities
-420.072
225.803000000363
-645.00
-286.03%
Cash Flow from Financing Activities
870.52
166.944000000268
704.00
421.44%
Net Cash Inflow / Outflow
-8.206
-177.823000000286
169.00
95.39%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
4.197
0
4.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Sep'24
YoY Growth in year ended Sep 2024 is -200.77% vs -13.05% in Sep 2023
Sep'24
Sep'23
Change(%)
Cash Flow from Operating Activities
-462.85
-153.89
-200.77%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
